Sinofn Health Sinofn Health

OEM SINOFN Health Supplement Technologies

Science-Driven Contract Manufacturing for Global Nutraceutical Leaders

Featured Solutions

Strategic Industry Insights & Global Solutions

The Evolution of Nutraceutical OEM

In the contemporary wellness landscape, the shift from generic supplementation to "Personalized Nutrition" is accelerating. SINOFN Health Supplement Technologies stands at the intersection of this transition. By leveraging our deep-rooted partnership with the Chinese Academy of Sciences (CAS), we provide more than just manufacturing; we offer a technical gateway for global brands to enter complex health markets.

Macro Industry Status

Global demand is trending towards Bioavailability and Regulatory Transparency. Our strategy focuses on "Information Gain"—providing clients with clinical stability data, ingredient provenance, and manufacturing traceability that helps their products stand out on crowded shelves.

Expertise and Innovation

🔬

Medical Innovation

Led by Dr. Tan Shengjie (Peking University), focusing on metabolic disorder formulations and precision nutrition.

🧪

R&D Leadership

Dr. Zhang Ying (CAS Postdoc) drives our research into bioactive compound delivery systems and product efficacy.

🌍

EU Regulatory Tech

Hans van Dijk, our Dutch Chief Engineer, ensures that our formulations meet the stringent requirements of EU and global nutraceutical standards.

🏭

Scalable Production

53,000 sqm of GMP-certified infrastructure delivering 500M+ units annually with absolute safety compliance.

Technical Roadmap & Localization Support

The SINOFN 2025 Vision

Our roadmap emphasizes three pillars: Bio-Efficiency, Digital Traceability, and Regional Customization. We aren't just a supplier; we are your localized R&D arm. Whether you require specific regulatory dossiers for the EU market, or market-specific taste profiling for North American consumers, our team manages the complexity so you can focus on brand growth.

71+
Registered Trademarks

Strategic FAQ

Why is SINOFN’s "Science-First" approach beneficial for startups?

Startups often lack internal R&D infrastructure. We bridge this by providing pilot-scale prototyping that mimics mass production, reducing the "Time to Market" while ensuring efficacy.

How do you handle global regulatory differences?

With an international expert team including European formulation specialists, we map ingredients against local compliance databases (FDA, EFSA, etc.) before the first batch is even produced.